BRCA1 and cancer: Presymptomatic testing is conducted upon the BRCA1, BRCA2, MLH1, MSH2 and the APC genes by bidirectional sequence analysis of duplicate DNA samples from the at risk relative alongside a control sample from the cancer-affected patient in which the familial pathogenic mutation has previously been identified.